Literature DB >> 1331175

High levels of circulating cytomegalovirus DNA reflect visceral organ disease in viremic immunosuppressed patients other than marrow recipients.

R L Saltzman1, M R Quirk, M C Jordan.   

Abstract

Although viremia is a hallmark of disseminated cytomegalovirus (CMV) infection, not all viremic patients have visceral organ CMV disease. We used blot hybridization with a cloned subgenomic probe to quantitate viral DNA in blood leukocytes of 60 viremic patients (25 with solid organ transplants, 20 with AIDS, and 15 marrow recipients) who had different clinical manifestations of CMV infection. The results are expressed as pg of viral DNA/10 micrograms of leukocyte DNA. Patients with AIDS or with solid organ transplants who had CMV visceral organ disease had the largest amounts of viral DNA in their granulocytes (median 632 and 237 pg, respectively). These amounts were significantly greater than those in similar viremic patients without CMV visceral disease (17 and 21 pg; P < 0.005 and 0.002, respectively). All patients in the study with > 150 pg of CMV DNA in their granulocytes had visceral CMV disease. The amounts of viral DNA in granulocytes of AIDS and organ transplant patients with CMV retinitis were low (median 22 pg). Marrow transplant patients were unique in that the amounts of CMV DNA in granulocytes were low whether CMV visceral organ disease was present (17 pg) or absent (14 pg). We conclude that high levels of circulating CMV DNA in viremic AIDS and solid organ transplant patients reflect viral involvement of visceral organs but not the retina. In marrow recipients, the severity of CMV disease, even when fatal, is not reflected quantitatively in peripheral blood leukocytes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1331175      PMCID: PMC443243          DOI: 10.1172/JCI116059

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  62 in total

1.  Cytomegaloviremia in children with acute lymphocytic leukemia.

Authors:  F Cox; W T Hughes
Journal:  J Pediatr       Date:  1975-08       Impact factor: 4.406

2.  Quantitation of cytomegalovirus DNA by blot hybridization in blood leukocytes of viremic patients.

Authors:  R L Saltzman; M R Quirk; C N Mariash; M C Jordan
Journal:  J Virol Methods       Date:  1990-10       Impact factor: 2.014

3.  A prospective analysis interstitial pneumonia and opportunistic viral infection among recipients of allogeneic bone marrow grafts.

Authors:  P E Neiman; W Reeves; G Ray; N Flournoy; K G Lerner; G E Sale; E D Thomas
Journal:  J Infect Dis       Date:  1977-12       Impact factor: 5.226

4.  Interstitial pneumonitis during murine cytomegalovirus infection and graft-versus-host reaction. Characterization of bronchoalveolar lavage cells.

Authors:  J D Shanley; C S Via; S O Sharrow; G M Shearer
Journal:  Transplantation       Date:  1987-11       Impact factor: 4.939

5.  Reciprocal enhancement of gene expression and viral replication between human cytomegalovirus and human immunodeficiency virus type 1.

Authors:  W Z Ho; J M Harouse; R F Rando; E Gönczöl; A Srinivasan; S A Plotkin
Journal:  J Gen Virol       Date:  1990-01       Impact factor: 3.891

6.  Localization of human cytomegalovirus in peripheral blood leukocytes by in situ hybridization.

Authors:  W M Dankner; J A McCutchan; D D Richman; K Hirata; S A Spector
Journal:  J Infect Dis       Date:  1990-01       Impact factor: 5.226

7.  Cytomegalovirus excretion as a predictor of cytomegalovirus disease after marrow transplantation: importance of cytomegalovirus viremia.

Authors:  J D Meyers; P Ljungman; L D Fisher
Journal:  J Infect Dis       Date:  1990-08       Impact factor: 5.226

8.  A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants; The City of Hope-Stanford-Syntex CMV Study Group.

Authors:  G M Schmidt; D A Horak; J C Niland; S R Duncan; S J Forman; J A Zaia
Journal:  N Engl J Med       Date:  1991-04-11       Impact factor: 91.245

9.  Cytomegalovirus retinitis secondary to chronic viremia in phagocytic leukocytes.

Authors:  M Fiala; S N Chatterjee; S Carson; S Poolsawat; D C Heiner; A Saxon; L B Guze
Journal:  Am J Ophthalmol       Date:  1977-10       Impact factor: 5.258

10.  Interaction of cytomegalovirus with leukocytes from patients with mononucleosis due to cytomegalovirus.

Authors:  C R Rinaldo; P H Black; M S Hirsch
Journal:  J Infect Dis       Date:  1977-11       Impact factor: 5.226

View more
  26 in total

1.  Clinical relevance of direct quantification of pp65 antigenemia using flow cytometry in solid organ and stem cell transplant recipients.

Authors:  A S Poirier-Toulemonde; N Milpied; D Cantarovich; J F Morcet; S Billaudel; B M Imbert-Marcille
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

2.  Evaluation of the COBAS AMPLICOR CMV MONITOR test for detection of viral DNA in specimens taken from patients after liver transplantation.

Authors:  I G Sia; J A Wilson; M J Espy; C V Paya; T F Smith
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

3.  The intracellular localization of human cytomegalovirus DNA in peripheral blood leukocytes during active infections by high-resolution fluorescence in situ hybridization.

Authors:  H Hackstein; H Kirchner; G Jahn; G Bein
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

4.  Evaluation of the AMPLICOR cytomegalovirus test with specimens from human immunodeficiency virus-infected subjects.

Authors:  G Boivin; J Handfield; E Toma; G Murray; R Lalonde; V J Tevere; R Sun; M G Bergeron
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

5.  Quantitation of cytomegalovirus (CMV) DNA in leukocytes of human immunodeficiency virus-infected subjects with and without CMV disease by using PCR and the SHARP Signal Detection System.

Authors:  G Boivin; J Handfield; G Murray; E Toma; R Lalonde; J G Lazar; M G Bergeron
Journal:  J Clin Microbiol       Date:  1997-02       Impact factor: 5.948

6.  Minimal effect of delayed sample processing on results of quantitative PCR for cytomegalovirus DNA in leukocytes compared to results of an antigenemia assay.

Authors:  P Schäfer; W Tenschert; K Gutensohn; R Laufs
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

Review 7.  Management of cytomegalovirus infection after solid-organ or stem-cell transplantation. Current guidelines and future prospects.

Authors:  H Hebart; L Kanz; G Jahn; H Einsele
Journal:  Drugs       Date:  1998-01       Impact factor: 9.546

Review 8.  New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients.

Authors:  I G Sia; R Patel
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

9.  Quantitative analysis of cytomegalovirus (CMV) viremia using the pp65 antigenemia assay and the COBAS AMPLICOR CMV MONITOR PCR test after blood and marrow allogeneic transplantation.

Authors:  G Boivin; R Bélanger; R Delage; C Béliveau; C Demers; N Goyette; J Roy
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

Review 10.  Clinical utility of viral load in management of cytomegalovirus infection after solid organ transplantation.

Authors:  Raymund R Razonable; Randall T Hayden
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.